Evaluating the Progression of Large Language Model Capabilities for Small-Molecule Drug Design

2026-04-17

AI Summary

This work addresses the lack of realistic benchmarks for evaluating large language models in small-molecule drug design by formalizing drug discovery tasks as a chemistry-oriented reinforcement learning environment. The proposed framework integrates molecular property prediction, representation translation, and molecule generation, enabling unified evaluation and efficient post-training. Through targeted reinforcement learning fine-tuning of smaller language models under low-data regimes, the approach achieves substantial performance gains—matching or even surpassing state-of-the-art large models—thereby demonstrating the effectiveness and practical feasibility of this paradigm for accelerating drug discovery.

Technology Category

• Machine Learning: Reinforcement Learning
• Natural Language Processing: (Large) Language Models
• Search and Optimization: Learning to Search

Application Category

• Search and Retrieval-Augmented AI: Large language models for search
• User Modeling, Personalization and Recommendation: Large Language Models (LLM) for user modeling and recommendation
• Graph Algorithms and Modeling for the Web: Foundation models and LLMs for Web-related graphs

Abstract

Large Language Models (LLMs) have the potential to accelerate small molecule drug design due to their ability to reason about information from diverse sources and formats. However, their practical utility remains unclear due to the lack of benchmarks that reflect real-world scenarios. In this work, we introduce a suite of chemically-grounded tasks spanning molecular property prediction, molecular representation transformations, and molecular design. Importantly, we formulate these tasks as reinforcement learning (RL) environments, enabling a unified approach for evaluation and post-training. Across three model families, we find that frontier models are increasingly proficient at chemical tasks, but that there is significant room for improvement, especially in experimental settings with low data. Critically, we show that RL-based post-training can substantially improve performance. A smaller model post-trained on our environments becomes competitive with state-of-the-art frontier models, despite a significantly weaker base model. This suggests a practical route toward employing LLMs in drug discovery; by combining carefully-designed evaluation tasks with targeted post-training, we can both elucidate and close critical capability gaps.

Problem

• Large Language Models
• small-molecule drug design
• benchmark
• real-world scenarios
• capability evaluation

Innovation

• reinforcement learning
• large language models
• molecular design
• post-training
• drug discovery